CHCT · Community Healthcare Trust Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31.52M | - | $31.09M | $29.09M | $30.08M | - | $29.64M | $27.52M | $29.33M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $5.11M | - | $4.66M | $10.56M | $5.10M | - | $4.93M | $4.76M | $4.55M | - |
| Total Operating Expenses | $22.13M | - | $21.49M | $27.02M | $22.14M | - | $21.85M | $21.12M | $20.61M | - |
| D&A | $10.66M | - | $10.90M | $10.88M | $10.94M | - | $10.93M | $10.79M | $10.26M | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $6.80M | - | $7.08M | $6.59M | $5.06M | - | $6.25M | $5.99M | $5.06M | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | $2.55M | - | $1.64M | ($12.56M) | $1.59M | - | $1.75M | ($10.43M) | $3.67M | - |
| EPS - Basic | $0.07 | - | $0.03 | ($0.50) | $0.03 | - | $0.04 | ($0.42) | $0.11 | - |
| EPS - Diluted | $0.07 | - | $0.03 | ($0.50) | $0.03 | - | $0.04 | ($0.42) | $0.11 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.62M | $3.34M | $3.38M | $4.86M | $2.27M | $4.38M | $2.84M | $734.0K | $3.81M | $3.49M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $1.01B | $990.76M | $987.26M | $966.29M | $985.11M | $992.56M | $981.78M | $983.20M | $982.70M | $945.41M |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $559.26M | $532.20M | $530.14M | $500.08M | $496.02M | $485.95M | $473.72M | $457.63M | $442.32M | $403.26M |
| Total Liabilities | $588.75M | $561.37M | $560.44M | $528.47M | $523.79M | $516.60M | $504.63M | $485.43M | $471.06M | $432.16M |
| Stockholders' Equity | $421.34M | $429.39M | $426.82M | $437.82M | $461.32M | $475.96M | $477.15M | $497.77M | $511.65M | $513.26M |
| Retained Earnings | - | - | - | - | - | - | - | - | - | - |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $13.74M | - | - | - | $14.41M | - | - | - | $12.64M | - |
| Investing Cash Flow | ($27.47M) | - | - | - | ($12.59M) | - | - | - | ($38.54M) | - |
| Financing Cash Flow | $13.00M | - | - | - | ($3.93M) | - | - | - | $26.21M | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | 8.1% | - | 5.3% | -43.2% | 5.3% | - | 5.9% | -37.9% | 12.5% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 16.2% | - | 15.0% | 36.3% | 17.0% | - | 16.7% | 17.3% | 15.5% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | 0.3% | - | 0.2% | -1.3% | 0.2% | - | 0.2% | -1.1% | 0.4% | - |
| Return on equity | 0.6% | - | 0.4% | -2.9% | 0.3% | - | 0.4% | -2.1% | 0.7% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 1.33 | 1.24 | 1.24 | 1.14 | 1.08 | 1.02 | 0.99 | 0.92 | 0.86 | 0.79 |
| Debt / Assets | 0.55 | 0.54 | 0.54 | 0.52 | 0.50 | 0.49 | 0.48 | 0.47 | 0.45 | 0.43 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 2.40 | 2.31 | 2.31 | 2.21 | 2.14 | 2.09 | 2.06 | 1.98 | 1.92 | 1.84 |
| Liabilities / Assets | 0.58 | 0.57 | 0.57 | 0.55 | 0.53 | 0.52 | 0.51 | 0.49 | 0.48 | 0.46 |
| Efficiency | ||||||||||
| Asset turnover | 0.03 | - | 0.03 | 0.03 | 0.03 | - | 0.03 | 0.03 | 0.03 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 227.0x | - | 510.0x | - | 605.3x | - | 453.7x | - | 241.4x | - |
| P / B | 1.0x | - | 1.0x | 1.0x | 1.1x | - | 1.0x | 1.2x | 1.4x | - |
| P / S | 13.6x | - | 13.3x | 15.3x | 16.1x | - | 16.3x | 22.5x | 23.8x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 4.8% | - | 4.9% | 5.7% | 2.5% | - | 3.1% | -1.1% | 7.9% | - |
| Revenue CAGR (3y) | 5.1% | - | 7.8% | 6.5% | 8.6% | - | 8.4% | 6.6% | 11.1% | - |
| Revenue CAGR (5y) | 8.1% | - | 10.0% | 9.7% | 10.9% | - | 12.8% | 14.0% | 16.9% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | 60.2% | - | -6.2% | -20.4% | -56.6% | - | -49.9% | - | - | - |
| EPS growth (YoY) | 133.3% | - | -25.0% | -19.0% | -72.7% | - | -63.6% | - | - | - |
| EPS CAGR (3y) | - | - | -47.7% | - | -47.7% | - | -41.5% | - | -19.4% | - |
| EPS CAGR (5y) | -19.7% | - | -32.9% | - | -30.1% | - | -19.7% | - | 12.9% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -8.7% | -9.8% | -10.5% | -12.0% | -9.8% | -7.3% | -8.6% | -1.5% | 3.5% | 3.3% |
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing Community Healthcare Trust Inc against the 5 most active filers in the same SIC group.
Dividends
$1.91/share trailing 12 months · +2.1% YoY
| Ex-date | Per share |
|---|---|
| May 11, 2026 | $0.4800 |
| Feb 23, 2026 | $0.4780 |
| Nov 7, 2025 | $0.4750 |
| Aug 8, 2025 | $0.4730 |
| May 9, 2025 | $0.4700 |
| Feb 24, 2025 | $0.4680 |
| Nov 8, 2024 | $0.4650 |
| Aug 9, 2024 | $0.4630 |
| May 9, 2024 | $0.4600 |
| Feb 16, 2024 | $0.4580 |
| Nov 8, 2023 | $0.4550 |
| Aug 10, 2023 | $0.4530 |
| May 11, 2023 | $0.4500 |
| Feb 17, 2023 | $0.4480 |
| Nov 9, 2022 | $0.4450 |
| Aug 11, 2022 | $0.4430 |
| May 12, 2022 | $0.4400 |
| Feb 18, 2022 | $0.4380 |
| Nov 10, 2021 | $0.4350 |
| Aug 12, 2021 | $0.4330 |
| May 13, 2021 | $0.4300 |
| Feb 24, 2021 | $0.4280 |
| Nov 13, 2020 | $0.4250 |
| Aug 14, 2020 | $0.4230 |